Liaoning Cheng Da Co

Liaoning Cheng Da Co EBITDA per Share

The EBITDA per Share of Liaoning Cheng Da Co (600739.SS) as of Oct 31, 2026 is 0.60 CNY. In the previous year, EBITDA per Share was 0.19 CNY — a change of 214.07% (higher).

EBITDA per Share

0.60CNY

YoY

214.07%

Last updated:

EBITDA per Share of Liaoning Cheng Da Co is 2024 0.60 CNY. EBITDA per Share of Liaoning Cheng Da Co was 2023 0.19 CNY. It decreases by 214.07% higher compared to the previous year.

The Liaoning Cheng Da Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2017
1.39 CNY
Jan 1, 2018
0.50 CNY
Jan 1, 2019
1.00 CNY
Jan 1, 2020
0.32 CNY
Jan 1, 2021
1.81 CNY
Jan 1, 2022
1.22 CNY
Jan 1, 2023
0.19 CNY
Jan 1, 2024
0.60 CNY
The Liaoning Cheng Da Co EBITDA per Share history
YEAREBITDA per ShareYoY
0.60CNY+214.07%
0.19CNY-84.30%
1.22CNY-32.56%
1.81CNY+461.18%
0.32CNY-67.76%
1.00CNY+101.57%
0.50CNY-64.30%
1.39CNY+30.87%
1.06CNY-9.89%
1.18CNY+54.72%
0.76CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Liaoning Cheng Da Co Stock analysis

What does Liaoning Cheng Da Co do? Liaoning Cheng Da Co., Ltd. generates revenue through four business segments. The Commodity Trading segment sells pharmaceuticals, oil, coal, and steel to retail and wholesale customers. The Biopharmaceutical Manufacturing segment develops and markets human and animal vaccines. The Energy Development segment extracts and sells oil. The Financial Services segment manages long-term investments and funds. The company serves domestic and international markets with these products and services. The firm's pharmaceutical and commodity trading activities target healthcare providers and industrial clients. Vaccine production caters to medical and veterinary markets. Oil sales focus on energy sector buyers. Investment services attract institutional and private investors. All segments operate across China and global markets. Liaoning Cheng Da's revenue streams include pharmaceutical retail and wholesale, commodity trading, vaccine sales, oil production, and financial fund management. The company's diverse portfolio spans healthcare, energy, and finance sectors. Its operations serve both local and international clients through established distribution channels. Liaoning Cheng Da Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Liaoning Cheng Da Co stock

EBITDA per Share of Liaoning Cheng Da Co is 0.60 CNY in 2024.

EBITDA per Share of Liaoning Cheng Da Co changed from 0.19 CNY to 0.60 CNY, representing a 214.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Liaoning Cheng Da Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Liaoning Cheng Da Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Liaoning Cheng Da Co